Search results
Results from the WOW.Com Content Network
Structure of the classical cephalosporins. The cephalosporins (sg. / ˌ s ɛ f ə l ə ˈ s p ɔːr ɪ n, ˌ k ɛ-,-l oʊ-/ [1] [2]) are a class of β-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as Cephalosporium. [3] Together with cephamycins, they constitute a subgroup of β-lactam antibiotics ...
This is a list of common β-lactam antibiotics—both administered drugs and those not in clinical use—organized by structural class. Antibiotics are listed alphabetically within their class or subclass by their nonproprietary name. If an antibiotic is a combination drug, both ingredients will be listed.
Cephalosporins (Third generation) Cefixime (antagonistic with Chloramphenicol) [6] Cefspan (Fujisawa), Suprax: Improved coverage of Gram-negative organisms, except Pseudomonas. Reduced Gram-positive cover. But still not cover Mycoplasma and Chlamydia: Gastrointestinal upset and diarrhea; Nausea (if alcohol taken concurrently) Allergic reactions
β-Lactam antibiotics are indicated for the prevention and treatment of bacterial infections caused by susceptible organisms. At first, β-lactam antibiotics were mainly active only against gram-positive bacteria, yet the recent development of broad-spectrum β-lactam antibiotics active against various gram-negative organisms has increased their usefulness.
Pages in category "Cephalosporin antibiotics" The following 75 pages are in this category, out of 75 total. This list may not reflect recent changes. ...
Cefepime is a broad-spectrum cephalosporin antibiotic and has been used to treat bacteria responsible for causing pneumonia and infections of the skin and urinary tract. Some of these bacteria include Pseudomonas, Escherichia, and Streptococcus species. The following represents MIC susceptibility data for a few medically significant ...
It is in the third-generation cephalosporin class of medications. [5] It works by disrupting the bacteria's cell wall resulting in its death. [5] Cefixime was patented in 1979 and approved for medical use in the United States in 1989. [5] [8] It is on the World Health Organization's List of Essential Medicines. [9]
The most frequent adverse drug reaction was diarrhea (1.30%) that resolved or subsided during treatment or after discontinuation or completion of therapy in all cases. [ 14 ] Data from the clinical studies carried out with cefditoren in the treatment of pharyngotonsillitis from 2007 to 2010 in Japan showed that the percentage of adverse events ...